Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 1
Submit an article Journal homepage
3,237
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study

John Kuruvillaa Princess Margaret Cancer Centre, Toronto, CanadaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6117-320XView further author information
ORCID Icon,
Philippe Armandb Dana-Farber Cancer Institute, Boston, MA, USAView further author information
,
Mehdi Hamadanic Medical College of Wisconsin, Milwaukee, WI, USAView further author information
,
Justin Klined Department of Medicine, University of Chicago, Chicago, IL, USAView further author information
,
Craig H. Moskowitze Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USAView further author information
,
David Aviganf Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USAView further author information
,
Joshua D. Brodyg Icahn School of Medicine at Mount Sinai, New York, NY, USAORCID Iconhttps://orcid.org/0000-0002-0850-6730View further author information
ORCID Icon,
Vincent Ribragh Gustave Roussy, Villejuif, FranceView further author information
,
Alex F. Herrerai City of Hope, Duarte, CA, USAView further author information
,
Franck Morschhauserj Department of Hematology, CHU Lille, Lille University, Lille, FranceORCID Iconhttps://orcid.org/0000-0002-3714-9824View further author information
ORCID Icon,
Abraham Kanatek HonorHealth Cancer Transplant Institute, Scottsdale, AZ, USAView further author information
,
Pier Luigi Zinzanil IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia “Seràgnoli”, Bologna, Italy;m Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, ItalyView further author information
,
Jacob Bitrann Advocate Lutheran General Hospital, Park Ridge, IL, USAView further author information
,
Herve Ghesquiereso Lyon-Sud Hospital Center, Lyon, FranceORCID Iconhttps://orcid.org/0000-0002-3131-3718View further author information
ORCID Icon,
Stephen J. Schusterp Department of Medicine, Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USAView further author information
,
Mohammed Farooquiq Merck & Co., Inc., Rahway, NJ, USAView further author information
,
Patricia Marinelloq Merck & Co., Inc., Rahway, NJ, USAView further author information
&
Nancy L. Bartlettr Siteman Cancer Center, Washington University, St. Louis, MO, USAORCID Iconhttps://orcid.org/0000-0001-8470-394XView further author information
ORCID Icon show all
Pages 130-139 | Received 13 Jul 2022, Accepted 12 Oct 2022, Published online: 18 Nov 2022

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.